SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
28-Nov-22 4:33 PM View: | Lipocine Inc. (LPCN) | 22-Nov-22 | Private Purchase | 21,739 | $0.47 | $10,217.30 | 100% 0 to 21.74K | |
22-Nov-22 9:45 PM View: | Vigil Neuroscience, Inc. (VIGL) | 18-Nov-22 | Option Exercise | 300 | $1.89 | $567.00 | 8% 4.0K to 4.3K | |
22-Nov-22 9:45 PM View: | Vigil Neuroscience, Inc. (VIGL) | 18-Nov-22 | Planned Option Sale | 300 | $14.00 | $4,200.00 | (7%) 4.3K to 4.0K | |
04-May-22 7:00 AM View: | Vigil Neuroscience, Inc. (VIGL) | 03-May-22 | Purchase | 4,000 | $3.40 | $13,591.20 | 100% 0 to 4.0K | |
24-Nov-21 4:09 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 24-Nov-21 | Disposition (change in control) | 20,975 | -- | -- | (100%) 20.98K to 0 | |
04-Jun-21 4:16 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 02-Jun-21 | Grant | 5,000 | -- | -- | 31% 15.97K to 20.98K | |
15-Mar-21 3:24 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 11-Mar-21 | Market Purchase | 5,975 | $5.06 | $30,233.50 | 60% 10.0K to 15.97K | 61% |
24-Nov-20 5:57 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 22-Nov-20 | Grant | 10,000 | -- | -- | 100% 0 to 10.0K |